Prothena Corporation plc (PRTA) Insider Trading Activity

NASDAQ$8.41+0.2 (2.44%)
Market Cap
$421.48M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
43 of 849
Rank in Industry
31 of 491

PRTA Insider Trading Activity

PRTA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$11,231,433
17
89
Sells
$135,975
2
11

Related Transactions

SCULLY WILLIAM P10 percent owner
17
$11.23M
0
$0
$11.23M
Kingston Anne EvansChief Strategy Officer
0
$0
1
$64,919
$-64,919
Isaacs Michael JohnGeneral Counsel & Company Sec.
0
$0
1
$71,055
$-71,055

About Prothena Corporation plc

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau …

Insider Activity of Prothena Corporation plc

Over the last 12 months, insiders at Prothena Corporation plc have bought $11.23M and sold $135,975 worth of Prothena Corporation plc stock.

On average, over the past 5 years, insiders at Prothena Corporation plc have bought $18.69M and sold $26.1M worth of stock each year.

Highest buying activity among insiders over the last 12 months: SCULLY WILLIAM P (10 percent owner) — $11.23M.

The last purchase of 50,000 shares for transaction amount of $403,525 was made by SCULLY WILLIAM P (10 percent owner) on 2026‑10‑23.

List of Insider Buy and Sell Transactions, Prothena Corporation plc

2026-10-23PurchaseSCULLY WILLIAM P10 percent owner
50,000
0.0944%
$8.07
$403,525
+3.29%
2026-10-22PurchaseSCULLY WILLIAM P10 percent owner
100,000
0.1903%
$8.19
$818,520
+2.24%
2026-10-14PurchaseSCULLY WILLIAM P10 percent owner
10,000
0.0193%
$8.46
$84,569
+0.78%
2026-10-13PurchaseSCULLY WILLIAM P10 percent owner
100,000
0.1909%
$8.35
$835,480
+0.48%
2026-10-08PurchaseSCULLY WILLIAM P10 percent owner
90,000
0.171%
$8.57
$770,904
-2.26%
2026-10-07PurchaseSCULLY WILLIAM P10 percent owner
125,000
0.2365%
$8.40
$1.05M
-0.59%
2026-10-02PurchaseSCULLY WILLIAM P10 percent owner
100,000
0.1966%
$8.57
$857,240
+0.66%
2026-09-29PurchaseSCULLY WILLIAM P10 percent owner
162,000
0.3058%
$8.68
$1.41M
-4.33%
2026-09-28PurchaseSCULLY WILLIAM P10 percent owner
103,500
0.1957%
$8.60
$889,872
-3.50%
2026-09-02PurchaseSCULLY WILLIAM P10 percent owner
27,000
0.0504%
$9.47
$255,739
-12.49%
2026-08-20PurchaseSCULLY WILLIAM P10 percent owner
50,000
0.093%
$8.79
$439,430
-5.20%
2026-08-07PurchaseSCULLY WILLIAM P10 percent owner
37,500
0.0708%
$8.62
$323,220
-0.46%
2026-07-29SaleKingston Anne EvansChief Strategy Officer
7,662
0.0145%
$8.47
$64,919
+0.99%
2026-07-29SaleIsaacs Michael JohnGeneral Counsel & Company Sec.
8,386
0.0159%
$8.47
$71,055
+0.99%
2026-06-16PurchaseSCULLY WILLIAM P10 percent owner
20,000
0.0364%
$7.90
$157,990
+5.55%
2026-06-11PurchaseSCULLY WILLIAM P10 percent owner
125,000
0.2362%
$8.17
$1.02M
+5.51%
2026-06-04PurchaseSCULLY WILLIAM P10 percent owner
50,000
0.0961%
$9.31
$465,295
-5.95%
2026-06-02PurchaseSCULLY WILLIAM P10 percent owner
50,000
0.098%
$9.43
$471,300
-5.22%
2026-05-22PurchaseSCULLY WILLIAM P10 percent owner
100,000
0.1907%
$9.81
$981,300
-10.99%
2025-05-06SaleEcoR1 Capital, LLC10 percent owner
1.98M
3.8331%
$7.64
$15.16M
+23.40%
Total: 205
*Gray background shows transactions not older than one year

Insider Historical Profitability

39.16%
SCULLY WILLIAM P10 percent owner
1187000
2.3122%
$9.75M210
<0.0001%
EcoR1 Capital, LLC10 percent owner
5304596
10.3329%
$43.55M94
+87.11%
Kinney Gene G.President and CEO
12793
0.0249%
$105,030.53113
+13.42%
Schenk Dale B.President and CEO
3333
0.0065%
$27,363.9312
+5.51%
Nguyen TranChief Strategy Officer and CFO
3200
0.0062%
$26,272.00210
+10.25%
Nickerson TaraChief Business Officer
2000
0.0039%
$16,420.0017
+5.51%
HOMAN ARTHUR WChief Legal Officer
0
0%
$019
+21.36%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$3,887,391
114
13.01%
$433.37M
$31,123,523
108
6.46%
$387.86M
$24,384,691
42
-30.27%
$396.82M
$2,481,409
33
201.68%
$455.48M
$31,271,604
28
28.69%
$477.19M

PRTA Institutional Investors: Active Positions

Increased Positions89+42.18%9M+21.58%
Decreased Positions87-41.23%5M-11.12%
New Positions26New791,783New
Sold Out Positions28Sold Out1MSold Out
Total Postitions213+0.95%47M+10.46%

PRTA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fmr Llc$72,691.0014.63%7.9M00%2025-09-30
Blackrock, Inc.$33,105.006.66%3.6M-340,981-8.66%2025-09-30
Vanguard Group Inc$18,859.003.8%2.05M-126,378-5.81%2025-09-30
Armistice Capital, Llc$16,781.003.38%1.82M-412,000-18.43%2025-09-30
Rubric Capital Management Lp$14,171.002.85%1.54M+2MNew2025-09-30
Adar1 Capital Management, Llc$13,516.002.72%1.47M-2M-56.47%2025-09-30
Palo Alto Investors Lp$12,181.002.45%1.32M+49,275+3.87%2025-09-30
D. E. Shaw & Co., Inc.$12,102.002.44%1.32M+923,923+236%2025-09-30
Acadian Asset Management Llc$11,401.002.3%1.24M+221,065+21.71%2025-09-30
Geode Capital Management, Llc$9,379.001.89%1.02M+86,037+9.22%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.